Dapafyzin-M 10/1000 Tablet ER
Marketer
Care Formulation Labs Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (1000mg)
Overview Dapafyzin-M 10/1000 Tablet ER
Dapafyzin-M 10/1000 Extended-Release tablets combine two medications to manage type 2 diabetes. This dual-action therapy effectively lowers elevated blood glucose, thereby mitigating the risk of severe diabetic complications and promoting cardiovascular health. Dapafyzin-M 10/1000 ER can be administered with meals and should be taken consistently at the same time each day for optimal adherence. Dosage is determined by your physician; discontinuation requires medical consultation as abrupt cessation may lead to elevated blood sugar, potentially causing kidney impairment or vision loss. This medication forms part of a comprehensive treatment plan including dietary adjustments, physical activity, and weight management as directed by your doctor. Commonly reported side effects include throat irritation, nasal stuffiness, rhinorrhea, headache, nausea, emesis, and diarrhea. Adequate hydration is crucial to minimize dehydration. Genital fungal infections are a potential side effect; meticulous hygiene helps reduce this risk. Prior to commencing treatment, inform your physician of any pre-existing kidney or liver disease, urinary tract infections, or diuretic use. Pregnant or lactating individuals must consult their doctor before use. Limit alcohol consumption as it may heighten the probability of adverse events. Regular blood glucose monitoring is essential during therapy.
Primary Ingredients of Dapafyzin-M 10/1000 Tablet ER
No text provided to rephrase.
Uses of Dapafyzin-M 10/1000 Tablet ER
Managing type 2 diabetes
Major Benefits of Dapafyzin-M 10/1000 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Dapafyzin-M 10/1000 Tablet ER whole; do not chew, crush, or divide it. Administer this extended-release tablet with a meal.
Common Side effects of Dapafyzin-M 10/1000 Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapafyzin-M 10/1000 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapafyzin-M 10/1000 Tablet ER whole; do not damage or alter the tablet in any way. Administer this medicine with a meal.
How Dapafyzin-M 10/1000 Tablet ER works:
Dapagliflozin and Metformin, combined as Dapafyzin-M 10/1000 Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates glucose excretion via the kidneys, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual action promotes superior blood sugar control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapafyzin-M 10/1000 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dapafyzin-M 10/1000 tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dapafyzin-M 10/1000 tablets are likely not safe for use while breastfeeding. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
The extended-release Dapafyzin-M 10/1000 tablet requires careful administration for individuals with impaired renal function. Dosage modifications of Dapafyzin-M 10/1000 may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Dapafyzin-M 10/1000 ER tablets. Dosage modification of Dapafyzin-M 10/1000 ER tablets may be necessary. Physician consultation is advised.
What if you forget to take Dapafyzin-M 10/1000 Tablet ER :
Should you forget a Dapafyzin-M 10/1000 Tablet ER dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapafyzin-M 10/1000 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |





